Novo Nordisk shares fell 9% today following news that the weight loss…

Comunitate

· Mar 10

Novo Nordisk shares fell 9% today following news that the weight loss drug CagriSema was not as effective as expected in clinical trials. Investors may not be happy with such news, but on the other hand, this decline can be used to increase the position.

What do you think about this news? Are you buying $NVO after today's drop?

Gareth Preston @gaz_preston Mar 11

I've got a smaller position and I'll hold for now. Right now I'm more buying and taking advantage of the downturn in tech stocks.

Bill Combs @billcombs Mar 16

Great, yeah I'm buying mostly the big tech now too.

Malcolm Stokes @stokes_malky Mar 11

I bought$NVO after the big drop, but I plan to increase my position today. The fact that the drug is not doing so well is not good news, but it is still a great success.

Clive Bennett @_clivy Mar 12

The company has been very successful and the business is doing well, but they are competing a lot with $LLY.

⌘ K

StockBot Live

Situația pieței Wall Street

Cipurile revin și urcă Wall Street spre recorduri

S&P 500 +0.57% și Nasdaq +1.09% au urcat pe fondul revenirii AI și Broadcom. Dow -0.10% a scăzut ușor.

Întrebați despre asta

StockBot cunoaște 80,000+ acțiuni la nivel mondial

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.